The platform is designed to match the most suitable drug delivery technologies to the API with the goal of providing optimal candidate formulations for animal pharmacokinetic studies.
Catalent Pharma Solutions is launching its new OptiForm Solution Suite platform at CPhI Worldwide 2015. The platform, which combines four technologies, including advanced parallel screening, is designed to match the most suitable drug delivery technologies to the API with the goal of providing optimal candidate formulations for animal pharmacokinetic studies in 12 weeks.
OptiForm Solution Suite aims to enhance drug bioavailability and to accelerate more molecules to the clinic and beyond.
Catalent is also showcasing several other advanced development and manufacturing technologies during the show, highlighting its tech transfer capabilities and flexible manufacturing solutions, including custom manufacturing suites, and the ability to handle cytotoxic and highly potent APIs. The company will detail how it has successfully combined these facilities and expertise to launch 175 new products to the market in 2014.
Catalent executives will be speaking at the Exhibitor Showcase:
Catalent is also participating in two Pharma Insight Briefings during the show:
Source: Catalent, Booth 3G10
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.